406 related articles for article (PubMed ID: 15191068)
1. Keys to unlocking the mysteries of rheumatic autoimmune disease.
Moser KL; Gaffney P; Peterson E; Behrens T
Minn Med; 2004 May; 87(5):46-51. PubMed ID: 15191068
[TBL] [Abstract][Full Text] [Related]
2. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool.
Centola M; Frank MB; Bolstad AI; Alex P; Szanto A; Zeher M; Hjelmervik TO; Jonsson R; Nakken B; Szegedi G; Szodoray P
Scand J Immunol; 2006 Sep; 64(3):236-42. PubMed ID: 16918692
[TBL] [Abstract][Full Text] [Related]
3. Are pediatric autoimmune diseases primarily genetic diseases?
Shaw EA; Stevens AM
Curr Opin Rheumatol; 2008 Sep; 20(5):589-94. PubMed ID: 18698183
[TBL] [Abstract][Full Text] [Related]
4. The genetics of complex autoimmune diseases: non-MHC susceptibility genes.
Wandstrat A; Wakeland E
Nat Immunol; 2001 Sep; 2(9):802-9. PubMed ID: 11526390
[TBL] [Abstract][Full Text] [Related]
5. The immune tolerance network and rheumatic disease: immune tolerance comes to the clinic.
Diamond B; Bluestone J; Wofsy D
Arthritis Rheum; 2001 Aug; 44(8):1730-5. PubMed ID: 11508422
[TBL] [Abstract][Full Text] [Related]
6. Strategies using functional genomics in rheumatic diseases.
Burmester GR; Häupl T
Autoimmun Rev; 2004 Nov; 3(7-8):541-9. PubMed ID: 15546803
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of susceptibility genes to rheumatic diseases].
Tsuchiya N; Tokunaga K
Nihon Rinsho; 1999 Feb; 57(2):323-8. PubMed ID: 10077998
[TBL] [Abstract][Full Text] [Related]
8. The dual association between lymphoma and autoimmunity.
Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
[TBL] [Abstract][Full Text] [Related]
9. HLA genes and predisposition to rheumatic diseases.
Arnett FC
Hosp Pract (Off Ed); 1986 Dec; 21(12):89-100. PubMed ID: 3098761
[No Abstract] [Full Text] [Related]
10. Shared familial aggregation of susceptibility to autoimmune diseases.
Hemminki K; Li X; Sundquist K; Sundquist J
Arthritis Rheum; 2009 Sep; 60(9):2845-7. PubMed ID: 19714648
[No Abstract] [Full Text] [Related]
11. [Histocompatibility HLA system in man. Considerations in the light of current concept. Part III. The relationship between HLA antigens and disease susceptibility].
Kedzierska A; Turowski G
Przegl Lek; 2001; 58(7-8):814-7. PubMed ID: 11769393
[TBL] [Abstract][Full Text] [Related]
12. Shared symptoms in rheumatic diseases: a blessing or a curse?
Huizinga TW; Gröndal G
Arthritis Rheum; 2009 Sep; 60(9):2547-9. PubMed ID: 19714580
[No Abstract] [Full Text] [Related]
13. HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity?
Brand O; Gough S; Heward J
Expert Rev Mol Med; 2005 Oct; 7(23):1-15. PubMed ID: 16229750
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling in human autoimmunity.
Baechler EC; Batliwalla FM; Reed AM; Peterson EJ; Gaffney PM; Moser KL; Gregersen PK; Behrens TW
Immunol Rev; 2006 Apr; 210():120-37. PubMed ID: 16623768
[TBL] [Abstract][Full Text] [Related]
15. [HLA antigens and rheumatic diseases].
Timofeev VT
Vopr Revm; 1982; (4):53-64. PubMed ID: 6760543
[No Abstract] [Full Text] [Related]
16. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.
Camargo JF; Correa PA; Castiblanco J; Anaya JM
Genes Immun; 2004 Dec; 5(8):609-14. PubMed ID: 15470475
[TBL] [Abstract][Full Text] [Related]
17. Malignancy and autoimmunity.
Bernatsky S; Ramsey-Goldman R; Clarke A
Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
[TBL] [Abstract][Full Text] [Related]
18. Biological therapies in autoimmune chronic inflammatory diseases (ACIDs).
Ferraccioli GF; Gremese E
Eur Rev Med Pharmacol Sci; 2006; 10(1):37-40. PubMed ID: 16494110
[TBL] [Abstract][Full Text] [Related]
19. The interferon signature in autoimmune diseases.
Rönnblom L; Eloranta ML
Curr Opin Rheumatol; 2013 Mar; 25(2):248-53. PubMed ID: 23249830
[TBL] [Abstract][Full Text] [Related]
20. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
